Guggenheim Capital LLC United Therapeutics Corp Transaction History

Guggenheim Capital LLC

  • $14 Billion
  • Q3 2024

A detailed history of Guggenheim Capital LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Guggenheim Capital LLC holds 15,378 shares of UTHR stock, worth $5.55 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
15,378
Previous 25,949 40.74%
Holding current value
$5.55 Million
Previous $8.27 Million 33.34%
% of portfolio
0.04%
Previous 0.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$311.04 - $363.55 $3.29 Million - $3.84 Million
-10,571 Reduced 40.74%
15,378 $5.51 Million
Q2 2024

Aug 14, 2024
SELL
$228.26 - $319.04 $735,225 - $1.03 Million
-3,221 Reduced 11.04%
25,949 $8.27 Million
Q1 2024

May 14, 2024
BUY
$210.76 - $249.51 $1.26 Million - $1.49 Million
5,975 Added 25.76%
29,170 $6.7 Million
Q4 2023

Feb 14, 2024
SELL
$214.88 - $256.94 $1.33 Million - $1.58 Million
-6,167 Reduced 21.0%
23,195 $5.1 Million
Q3 2023

Nov 14, 2023
BUY
$211.82 - $248.24 $34,738 - $40,711
164 Added 0.56%
29,362 $6.63 Million
Q2 2023

Aug 11, 2023
BUY
$205.19 - $232.99 $984,296 - $1.12 Million
4,797 Added 19.66%
29,198 $6.45 Million
Q1 2023

May 10, 2023
SELL
$212.99 - $276.17 $123,747 - $160,454
-581 Reduced 2.33%
24,401 $5.46 Million
Q4 2022

Feb 14, 2023
BUY
$205.95 - $280.43 $502,929 - $684,810
2,442 Added 10.83%
24,982 $6.95 Million
Q3 2022

Nov 14, 2022
SELL
$203.3 - $244.17 $1.36 Million - $1.63 Million
-6,668 Reduced 22.83%
22,540 $4.72 Million
Q2 2022

Aug 15, 2022
SELL
$174.81 - $241.14 $1.27 Million - $1.75 Million
-7,237 Reduced 19.86%
29,208 $6.88 Million
Q1 2022

May 16, 2022
SELL
$166.16 - $213.96 $8,308 - $10,698
-50 Reduced 0.14%
36,445 $6.54 Million
Q4 2021

Feb 14, 2022
BUY
$184.32 - $216.08 $52,899 - $62,014
287 Added 0.79%
36,495 $7.89 Million
Q3 2021

Nov 15, 2021
SELL
$179.86 - $214.88 $161,334 - $192,747
-897 Reduced 2.42%
36,208 $6.68 Million
Q2 2021

Aug 13, 2021
SELL
$170.47 - $211.93 $287,753 - $357,737
-1,688 Reduced 4.35%
37,105 $6.66 Million
Q1 2021

May 13, 2021
BUY
$153.94 - $174.85 $73,583 - $83,578
478 Added 1.25%
38,793 $6.49 Million
Q4 2020

Feb 16, 2021
SELL
$101.87 - $151.79 $180,411 - $268,820
-1,771 Reduced 4.42%
38,315 $5.82 Million
Q3 2020

Nov 13, 2020
BUY
$99.9 - $121.13 $449,050 - $544,479
4,495 Added 12.63%
40,086 $4.05 Million
Q2 2020

Aug 14, 2020
SELL
$92.74 - $125.82 $2.27 Million - $3.08 Million
-24,458 Reduced 40.73%
35,591 $4.31 Million
Q1 2020

Jun 02, 2020
SELL
$79.39 - $115.35 $716,653 - $1.04 Million
-9,027 Reduced 13.07%
60,049 $5.69 Million
Q4 2019

Feb 14, 2020
BUY
$78.31 - $95.34 $1.17 Million - $1.43 Million
14,980 Added 27.69%
69,076 $6.08 Million
Q3 2019

Nov 14, 2019
SELL
$74.85 - $85.99 $403,216 - $463,228
-5,387 Reduced 9.06%
54,096 $4.31 Million
Q2 2019

Aug 14, 2019
SELL
$76.06 - $120.81 $639,512 - $1.02 Million
-8,408 Reduced 12.38%
59,483 $4.64 Million
Q1 2019

May 15, 2019
BUY
$107.15 - $126.84 $1.27 Million - $1.5 Million
11,838 Added 21.12%
67,891 $7.97 Million
Q4 2018

Feb 14, 2019
SELL
$101.4 - $128.73 $187,285 - $237,764
-1,847 Reduced 3.19%
56,053 $6.1 Million
Q3 2018

Nov 14, 2018
SELL
$113.81 - $129.46 $2.36 Million - $2.69 Million
-20,779 Reduced 26.41%
57,900 $7.4 Million
Q2 2018

Aug 14, 2018
SELL
$101.14 - $118.31 $2.77 Million - $3.24 Million
-27,370 Reduced 25.81%
78,679 $8.9 Million
Q1 2018

May 15, 2018
BUY
$107.21 - $151.94 $302,117 - $428,166
2,818 Added 2.73%
106,049 $11.9 Million
Q4 2017

Feb 14, 2018
BUY
$118.58 - $151.28 $1.51 Million - $1.92 Million
12,694 Added 14.02%
103,231 $15.3 Million
Q3 2017

Nov 14, 2017
BUY
$114.6 - $136.81 $10.4 Million - $12.4 Million
90,537
90,537 $10.6 Million

Others Institutions Holding UTHR

# of Institutions
671
Shares Held
42.3M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email